Preparation and evaluation of spherical porous granules of octacalcium phosphate/hydroxyapatite as drug carriers in bone cancer treatment

Natsuko Ito, Masanobu Kamitakahara, Koji Ioku

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Spherical porous granules composed of octacalcium phosphate (OCP) and hydroxyapatite (HA) are predicted to be useful as drug carriers for treating bone cancer. We successfully prepared spherical porous OCP/HA granules by immersing α-tricalcium phosphate spherical granules in a pH 5.0 buffered solution at 60 C. When human osteosarcoma (HOS) cells were cultured in the medium in which the methotrexate-loaded granules were immersed, cell proliferation was significantly inhibited. The release of methotrexate from the granules continued for at least 48 h. On the other hand, the medium immersed in the methotrexate-free granules did not inhibit the cell proliferation. These results suggest that the spherical porous OCP/HA granules are safe and act as drug carriers releasing the drugs continuously.

Original languageEnglish
Pages (from-to)94-96
Number of pages3
JournalMaterials Letters
Volume120
DOIs
Publication statusPublished - 2014 Apr 1

Fingerprint

Drug Carriers
Oncology
Durapatite
Hydroxyapatite
Methotrexate
bones
phosphates
Bone
Phosphates
drugs
cancer
Cell proliferation
preparation
evaluation
releasing
cultured cells
Pharmaceutical Preparations
octacalcium phosphate

Keywords

  • Biomaterials
  • Bone
  • Drug carrier
  • Hydroxyapatite
  • Octacalcium phosphate

ASJC Scopus subject areas

  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanical Engineering
  • Mechanics of Materials

Cite this

Preparation and evaluation of spherical porous granules of octacalcium phosphate/hydroxyapatite as drug carriers in bone cancer treatment. / Ito, Natsuko; Kamitakahara, Masanobu; Ioku, Koji.

In: Materials Letters, Vol. 120, 01.04.2014, p. 94-96.

Research output: Contribution to journalArticle

@article{afcca4fb1c5d4e90b4bc23b25726a26a,
title = "Preparation and evaluation of spherical porous granules of octacalcium phosphate/hydroxyapatite as drug carriers in bone cancer treatment",
abstract = "Spherical porous granules composed of octacalcium phosphate (OCP) and hydroxyapatite (HA) are predicted to be useful as drug carriers for treating bone cancer. We successfully prepared spherical porous OCP/HA granules by immersing α-tricalcium phosphate spherical granules in a pH 5.0 buffered solution at 60 C. When human osteosarcoma (HOS) cells were cultured in the medium in which the methotrexate-loaded granules were immersed, cell proliferation was significantly inhibited. The release of methotrexate from the granules continued for at least 48 h. On the other hand, the medium immersed in the methotrexate-free granules did not inhibit the cell proliferation. These results suggest that the spherical porous OCP/HA granules are safe and act as drug carriers releasing the drugs continuously.",
keywords = "Biomaterials, Bone, Drug carrier, Hydroxyapatite, Octacalcium phosphate",
author = "Natsuko Ito and Masanobu Kamitakahara and Koji Ioku",
year = "2014",
month = "4",
day = "1",
doi = "10.1016/j.matlet.2014.01.040",
language = "English",
volume = "120",
pages = "94--96",
journal = "Materials Letters",
issn = "0167-577X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Preparation and evaluation of spherical porous granules of octacalcium phosphate/hydroxyapatite as drug carriers in bone cancer treatment

AU - Ito, Natsuko

AU - Kamitakahara, Masanobu

AU - Ioku, Koji

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Spherical porous granules composed of octacalcium phosphate (OCP) and hydroxyapatite (HA) are predicted to be useful as drug carriers for treating bone cancer. We successfully prepared spherical porous OCP/HA granules by immersing α-tricalcium phosphate spherical granules in a pH 5.0 buffered solution at 60 C. When human osteosarcoma (HOS) cells were cultured in the medium in which the methotrexate-loaded granules were immersed, cell proliferation was significantly inhibited. The release of methotrexate from the granules continued for at least 48 h. On the other hand, the medium immersed in the methotrexate-free granules did not inhibit the cell proliferation. These results suggest that the spherical porous OCP/HA granules are safe and act as drug carriers releasing the drugs continuously.

AB - Spherical porous granules composed of octacalcium phosphate (OCP) and hydroxyapatite (HA) are predicted to be useful as drug carriers for treating bone cancer. We successfully prepared spherical porous OCP/HA granules by immersing α-tricalcium phosphate spherical granules in a pH 5.0 buffered solution at 60 C. When human osteosarcoma (HOS) cells were cultured in the medium in which the methotrexate-loaded granules were immersed, cell proliferation was significantly inhibited. The release of methotrexate from the granules continued for at least 48 h. On the other hand, the medium immersed in the methotrexate-free granules did not inhibit the cell proliferation. These results suggest that the spherical porous OCP/HA granules are safe and act as drug carriers releasing the drugs continuously.

KW - Biomaterials

KW - Bone

KW - Drug carrier

KW - Hydroxyapatite

KW - Octacalcium phosphate

UR - http://www.scopus.com/inward/record.url?scp=84893283024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893283024&partnerID=8YFLogxK

U2 - 10.1016/j.matlet.2014.01.040

DO - 10.1016/j.matlet.2014.01.040

M3 - Article

VL - 120

SP - 94

EP - 96

JO - Materials Letters

JF - Materials Letters

SN - 0167-577X

ER -